Time-course of drug-related psychiatric and behavioral treatment-emergent adverse events during brivaracetam treatment in adults with focal-onset seizures

Autor: Meador, Kimford J., Dimova, Svetlana, Bourikas, Dimitrios, Elmoufti, Sami, Floricel, Florin, Laloyaux, Cédric, Moseley, Brian, Nondonfaz, Xavier, Klein, Pavel

Publikováno v: In Epilepsy & Behavior July 2024 156

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials

Autor: Philippe Ryvlin, Svetlana Dimova, Sami Elmoufti, Florin Floricel, Cédric Laloyaux, Xavier Nondonfaz, Victor Biton

Publikováno v: Ryvlin, P, Dimova, S, Elmoufti, S, Floricel, F, Laloyaux, C, Nondonfaz, X & Biton, V 2022, ' Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use : Pooled results from three phase 3 trials ', Epilepsia, vol. 63, no. 8, pp. 2024-2036 . https://doi.org/10.1111/epi.17304

Objective: This study was undertaken to evaluate safety/tolerability and efficacy of adjunctive brivaracetam (BRV) in patients on one or two concomitant antiseizure medications (ASMs) and in patients on one specific concomitant ASM. Methods: Post hoc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe708e073149db2d42b0072ca0a277ba
https://pubmed.ncbi.nlm.nih.gov/35582748

Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures

Autor: Christian, Brandt, Svetlana, Dimova, Sami, Elmoufti, Cédric, Laloyaux, Xavier, Nondonfaz, Pavel, Klein

Publikováno v: Epilepsy & Behavior. 138:108967

To evaluate long-term retention, reasons for discontinuation, efficacy, tolerability, and health-related quality of life (HRQOL) during adjunctive brivaracetam (BRV) treatment in adults with focal seizures by number of lifetime antiseizure medication

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca98eca4f9abe613da693da58eb786db
https://doi.org/10.1016/j.yebeh.2022.108967

Effect of lifetime antiepileptic drug treatment history on efficacy and tolerability of adjunctive brivaracetam in adults with focal seizures: Post-hoc analysis of a randomized, placebo-controlled trial

Autor: Pavel Klein, Sami Elmoufti, Xavier Nondonfaz, Richard S. McLachlan, Kathy Foris, Svetlana Dimova, Christian Brandt

Publikováno v: Epilepsy research. 167

Objective To evaluate the efficacy and tolerability of adjunctive brivaracetam (BRV) in adults with focal seizures by the number of lifetime (previous and concomitant) antiepileptic drugs (AEDs). Methods Post-hoc analysis of data from N01358 (NCT0126

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30b1f116881b6a295e2631684dc7e7d1
https://pubmed.ncbi.nlm.nih.gov/32717713